What was the primary driver of Axon's revenue growth in Q2 2023?

Axon's revenue growth in Q2 2023 was primarily driven by strong performance across both its TASER and Software and Sensors segments. The introduction of the new TASER 10 device contributed to the TASER segment's growth, while continued expansion of cloud-based solutions and increased sales of Axon Fleet Systems fueled the Software and Sensors segment's significant increase.

Why did Axon's net income decrease significantly despite strong revenue growth?

The significant decrease in net income was primarily due to a substantial non-cash unrealized impairment loss of $71.9 million recognized on a strategic investment during the quarter. Excluding this one-time charge, the company's operational profitability, as indicated by income from operations, showed considerable improvement.

What is the significance of the $5.2 billion in remaining performance obligations?

The $5.2 billion in remaining performance obligations represents future contracted revenue that Axon expects to recognize over the next several years. This figure indicates a strong and predictable revenue pipeline, providing visibility into future financial performance, although subject to risks like contract cancellations or deployment delays.

How is the company addressing the material weakness identified in its internal controls?

Axon identified a material weakness related to revenue recognition and deferred revenue, stemming from issues during an ERP system implementation. The company is actively remediating this by designing and implementing new business processes, automating system integrations, and enhancing reconciliation controls and monitoring procedures to ensure transactions are recorded accurately and timely.

AXON 10-Q Quarterly Report Q2 FY2023 — Revenue, Net Income, EPS

Summary

Axon Enterprise, Inc. (AXON) reported strong top-line growth in its second quarter of 2023, with net sales increasing by 31.2% year-over-year to $374.6 million. This growth was driven by a significant increase in both the TASER and Software and Sensors segments. The TASER segment saw a 13.9% rise, largely due to the new TASER 10 device, while the Software and Sensors segment experienced robust growth of 46.8%, fueled by strong demand for Axon Evidence and Cloud Services and Axon Fleet Systems. Despite the revenue surge, net income saw a substantial decrease to $12.4 million from $51.0 million in the prior year's quarter. This decline was primarily due to a significant non-cash unrealized impairment loss of $71.9 million related to a strategic investment. However, excluding this impairment, the company's operational performance showed resilience, with income from operations more than doubling year-over-year. The company also highlighted substantial future contracted revenue of $5.2 billion, indicating strong future revenue potential.

Financial Highlights

52 data points

Beta

Revenue

$372.70M

0.6% Gross Margin

Net Income

$11.51M

0.0% Net Margin

EPS (Diluted)

$0.15

Total Assets

$3.08B

Cash & Equivalents

$476.20M

Free Cash Flow

$29.52M

Financial Statements

Beta

Revenue	$372.70M
Cost of Revenue	$142.36M
Gross Profit	$230.34M
R&D Expenses	$71.94M
SG&A Expenses	$119.31M
Operating Expenses	$191.25M
Operating Income	$39.09M
Net Income	$11.51M
EPS (Basic)	$0.16
EPS (Diluted)	$0.15
Shares Outstanding (Basic)	74.22M
Shares Outstanding (Diluted)	75.78M

Key Highlights

1Net sales grew 31.2% to $374.6 million in Q2 2023 compared to the prior year, driven by strong performance in both TASER and Software & Sensors segments.
2TASER segment revenue increased 13.9% year-over-year, primarily attributed to the launch of the new TASER 10 device.
3Software and Sensors segment revenue surged by 46.8% year-over-year, with notable growth in Axon Evidence, Cloud Services, and Axon Fleet Systems.
4Gross margin improved to 62.0% from 60.9% in the prior year's quarter, driven by a favorable product mix and improvements in the Software and Sensors segment.
5Income from operations significantly increased to $40.3 million from $21.4 million in Q2 2022.
6Net income decreased to $12.4 million from $51.0 million due to a $71.9 million non-cash impairment loss on a strategic investment.
7Remaining performance obligations (future contracted revenue) stood at a substantial $5.2 billion as of June 30, 2023.

AXON ENTERPRISE, INC. Quarterly Report for Q2 Ended Jun 30, 2023

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions